- Home
- GLPG vs SPNS Comparison
GLPG vs SPNS Comparison
Compare GLPG & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- SPNS
- Stock Information
- Founded
- GLPG 1999
- SPNS 1982
- Country
- GLPG Belgium
- SPNS Israel
- Employees
- GLPG N/A
- SPNS N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- SPNS Computer Software: Prepackaged Software
- Sector
- GLPG Health Care
- SPNS Technology
- Exchange
- GLPG Nasdaq
- SPNS Nasdaq
- Market Cap
- GLPG 1.8B
- SPNS 1.6B
- IPO Year
- GLPG 2005
- SPNS 1992
- Fundamental
- Price
- GLPG $27.73
- SPNS $29.72
- Analyst Decision
- GLPG Sell
- SPNS Buy
- Analyst Count
- GLPG 4
- SPNS 4
- Target Price
- GLPG $25.33
- SPNS $34.25
- AVG Volume (30 Days)
- GLPG 432.0K
- SPNS 129.5K
- Earning Date
- GLPG 07-31-2025
- SPNS 07-31-2025
- Dividend Yield
- GLPG N/A
- SPNS 3.20%
- EPS Growth
- GLPG N/A
- SPNS 11.11
- EPS
- GLPG N/A
- SPNS 1.30
- Revenue
- GLPG $311,493,731.00
- SPNS $544,235,000.00
- Revenue This Year
- GLPG $0.78
- SPNS $7.54
- Revenue Next Year
- GLPG N/A
- SPNS $6.90
- P/E Ratio
- GLPG N/A
- SPNS $22.86
- Revenue Growth
- GLPG 18.32
- SPNS 3.84
- 52 Week Low
- GLPG $22.36
- SPNS $23.69
- 52 Week High
- GLPG $31.23
- SPNS $41.22
- Technical
- Relative Strength Index (RSI)
- GLPG 50.32
- SPNS 69.31
- Support Level
- GLPG $28.57
- SPNS $28.32
- Resistance Level
- GLPG $29.41
- SPNS $28.84
- Average True Range (ATR)
- GLPG 0.52
- SPNS 0.45
- MACD
- GLPG -0.16
- SPNS 0.11
- Stochastic Oscillator
- GLPG 9.33
- SPNS 95.55
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.